National Consortium of Breast Centers
Ambry Genetics is a proud sponsor of the 2025 NCBC Annual Meeting and supporter of the NCBC organization. We invite you to visit us at booth 404+405 to learn more about Ambry's CARE program, our risk assessment tool that makes it easy to identify high-risk patients who qualify for hereditary cancer testing. Ambry offers paired DNA and RNA testing that helps identify more cases of hereditary cancer and fewer variants of uncertain significance (VUS).
Click HERE to learn more about Ambry's hereditary cancer testing or our other test offerings.
There were no additional registered posters or presentations.